CRA analyzed market definition in antitrust litigation concerning a product in the non-opioid pain category. In defining the relevant antitrust market, our work accounted for indicators of competition among branded pharmaceutical products, including market positioning, factors driving physician choice, development of new approved indications, and competition for formulary listing.
Great Thinkers in Marketing series features two chapters from CRA Competition expert
Two academic articles co-authored by CRA’s Dr. Tolga Bilgicer (as the lead author) have been published as two separate chapters in The Research Contributions...